Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer. Read more about Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer.
Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function. Read more about Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function.
Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate. Read more about Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate.
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer. Read more about How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer. Read more about Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer.
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier. Read more about Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry. Read more about Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer. Read more about Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer.
Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study. Read more about Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study.
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance. Read more about Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.
